HyperCKaemia: assessment
Evidence-based neurology checklist on hyperckaemia: assessment: Definitions HyperCKaemia: the CK is >1.5 times the upper limit of normal Mild elevation: the CK is <2 times the upper limit of normal Moderate elevation: the CK is 2-4 times the upper limit of normal Marked elevation: the CK is >4…
Definitions
- HyperCKaemia: the CK is >1.5 times the upper limit of normal
- Mild elevation: the CK is <2 times the upper limit of normal
- Moderate elevation: the CK is 2-4 times the upper limit of normal
- Marked elevation: the CK is >4 times the upper limit of normal
Indicators of insignificant raised CK
Adverse effects of hyperCKaemia: malignant hyperthermia (MH)
Indications for muscle biopsy with hyperCKaemia
Diagnostic outcomes of hyperCKaemia
Predictors of establishing a diagnosis
Diagnostic algorithm
References
- Morandi L, Angelini C, Prelle A, et al. High plasma creatine kinase: review of the literature and proposal for a diagnostic algorithm. Neurol Sci 2006; 27:303-311.
- Kyriakides T, Angelini C, Schefer J, et al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol 2010; 17:767-773.
- De Bleeker JL. How to approach the patient with muscular symptoms in the general neurological practice? Acta Neurol Belg 2005; 105:18-22.
- Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997; 84:1038-1041.
- Lingaraju N, Rosenberg H. Unexplained increases in serum creatine kinase levels: its relation to malignant hyperthermia susceptibility. Anesth Analg 1991; 72:702-705.
- And 6 more. Subscribe to see the full list
